Wayne G. Shreffler

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

59h-index12.8kcitations347works8.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Food Allergy and Anaphylaxis Research(215), Allergic Rhinitis and Sensitization(97), Eosinophilic Esophagitis(92), Asthma and respiratory diseases(62), Contact Dermatitis and Allergies(28)

Publications347 total

High Rate of Positive Fecal Occult Blood Test in Healthy Infants: A Nested Case-control Study
Journal of Translational Gastroenterology·2025· 1 citedOpen Access
GPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis
2025Open Access
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies
Journal of Allergy and Clinical Immunology·2025Open Access
Fecal calprotectin and other biomarkers are not prospectively associated with food protein‐induced allergic proctocolitis
Journal of Pediatric Gastroenterology and Nutrition·2025· 1 cited
DELAYED URTICARIA AND SERUM SICKNESS-LIKE REACTION IN A 4-YEAR-OLD RECEIVING OMALIZUMAB
Annals of Allergy Asthma & Immunology·2025Open Access
Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy
Journal of Allergy and Clinical Immunology·2025· 2 citedOpen Access
Strain-Level microbial signatures and inferred functional alterations in infants with Food Protein-Induced Allergic Proctocolitis
2025Open Access
Association of bile acids, amino acids, and glycerophospholipid metabolites with food-allergic outcomes in children on peanut oral immunotherapy
2025Open Access
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans
Science Translational Medicine·2025· 1 citedOpen Access
Introduction of allergenic foods after treatment with omalizumab
Journal of Allergy and Clinical Immunology·2025· 7 cited
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
Journal of Allergy and Clinical Immunology·2025· 2 citedOpen Access
Dietary plant diversity predicts early life microbiome maturation
2025· 2 citedOpen Access
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)
The Journal of Allergy and Clinical Immunology In Practice·2025· 4 cited
Moving Beyond Desensitization to Tolerance in Food Allergy
The Journal of Allergy and Clinical Immunology In Practice·2025· 6 cited
Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis
2025· 2 citedOpen Access
Characterization of a circulating milk-specific TCR clonotype in a child with EoE milk allergy
Journal of Allergy and Clinical Immunology·2025Open Access
Introduction Of Allergenic Foods After Treatment With Omalizumab
Journal of Allergy and Clinical Immunology·2025Open Access
Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT
Journal of Allergy and Clinical Immunology·2025· 5 cited
Measuring Time to Maintenance in Patients on Sesame Oral Immunotherapy
Journal of Allergy and Clinical Immunology·2025
First-in-human VLP Peanut Vaccine Candidate: Safety and Tolerability Data from on-going Phase I/IIa Clinical Trial
Journal of Allergy and Clinical Immunology·2025· 3 cited
page 1 of 18Next →

Frequent Co-authors

Hugh A. Sampson(19), Anna Nowak‐Węgrzyn(10), Stacie M. Jones(9), A. Wesley Burks(8), Robert A. Wood(8), Scott H. Sicherer(7), Brian P. Vickery(6), Edwin Kim(6), Bert Ruiter(6), Sarita U. Patil(5), Kirsten Beyer(5), J. Andrew Bird(5), Julie Wang(5), Bruce J. Lanser(5), Ludmilla Bardina(5), Amy M. Scurlock(4), Agustin Calatroni(4), Corinne Keet(4), R. Sharon Chinthrajah(4), Gordon L. Sussman(4)